Biovica International AB (OSTO:BIOVIC B)
kr 2.405 0.04 (1.69%) Market Cap: 202.15 Mil Enterprise Value: 130.57 Mil PE Ratio: 0 PB Ratio: 2.09 GF Score: 48/100

Q2 2023 Biovica International AB Earnings Call Transcript

Dec 15, 2022 / 02:00PM GMT
Release Date Price: kr8.29 (-2.01%)
Operator

All right. Hello, everyone, and welcome to the Biovica Q2 interim report for the fiscal year of '22/'23.

Today, I have my colleagues, Cecilia Driving, our EVP and CFO; and Warren Cresswell, President of Biovica Americas, with me. And together, we will present the highlights of the report. And this is the agenda for the call. First of all, I'll make a very short Biovica introduction as I assume that people that are watching this call are familiar with the company. If you want more information, you can find that on our web page with a lot of in-depth presentations.

I'll go through the highlights. Cecilia will cover the financials, and Warren will give you an update about the U.S. status and the launch, et cetera. And at the end, we will have a summary and a Q&A session, and you can already now post your questions. And if you want to be anonymous, you can do that as well. You have to check box in the bottom. And we will also have our research analysts Dan Akschuti from Pareto and possibly Johan Unnerus from Redeye right into the call asking questions.

So just a short update of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot